Doctors were paid a 6% commission on sales, incentivizing the prescription of products costing as much as $2,000 per cubic inch, compared to 35 cents in Europe. The Justice Department charged 11 defendants in June for more than $2 billion in allograft claims, including a company accused of issuing sham invoices to inflate reimbursement rates.
